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A BSTRACT  Xylocaine  and its derivatives  act  specifically at  the neuromuscu-
lar junction within the concentration  range 0.05  to  2.0  m.  The  charged form
is the active form of the drugs. There is no correlation between "local anesthetic"
activity  and effect at the junction.  Like  d-tubocurarine,  these drugs have little
or  no  effect  on quantum  content,  acetylcholinesterase  activity,  or the  passive
impedance  of the  muscle fiber.  Yet they  produce  end  plate  potentials  charac-
terized by a brief, early component and a late, greatly prolonged component, as
does  procaine.  Analysis  of these  changes in time  course  suggests that  the drugs
have little or no effect before receptors  are activated by acetylcholine,  but cause
a decreased  and often greatly prolonged  response.  Clear structure-activity  rela-
tions  indicate  that  the  receptor  to  which the  drugs  bind  to  produce  the pro-
longed response can be the receptor for acetylcholine.  Comparison  of the effects
of the drugs on the end plate potential and  on the response to  iontophoretically
applied  acetylcholine  also  shows  that the  effects  of Xylocaine  depend  on  the
time course  of receptor  activation  and  are quite  different  from the  effects  of d-
tubocurarine.
The  experiments  reported  here  were  prompted  by  previous  studies  on  the
effects of the local anesthetic procaine  at the neuromuscular junction  of frog
skeletal  muscle  (4,  10,  20,  21).  Procaine  has  been  found  to depress  the  am-
plitude of the  response of the postsynaptic  receptors  to  acetylcholine  (ACh)
(4).  But unlike d-tubocurarine  (d-TC),  which depresses  the amplitude  of the
end plate potential  (e.p.p.)  without greatly altering its time course  (rise time
of 1-2 msec and half-time of fall 2-8 msec  [9]) procaine produces  e.p.p.'s that
have an initial rapid transient  (rise  time 0.5-1  msec, half-time of fall  1 msec
or  less)  followed  by  a  greatly  prolonged  late  falling  phase  (10).  Maeno
(20,  21)  has shown  that  this prolonged  phase  arises  from a  prolonged  flow
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of end  plate  current,  and  he  concluded  that  procaine  acted  on  the  post-
synaptic  receptors  themselves.  Although  procaine  does  not  activate  re-
ceptors,  it can apparently  change  the time course of the activation produced
by ACh.
To  search  for  an  explanation  of the  change  in  the  time  course  of end
plate response,  I have  studied the action of Xylocainel  (lidocaine, lignocaine)
and  several  derivatives  at the  neuromuscular  junction.  Xylocaine's  molec-
TABLE  I
RELATIVE  EFFECTIVENESS  OF  XYLOCAINE
DERIVATIVES  IN  DECREASING  THE  AMPLITUDE
OF  THE  E.P.P.  IN  EDL  IV FIBERS
Values  calculated  from  at  least  three  experiments  for  each  chemical;  a
difference  of  40.05  is  probably  not  significant.  Also  shown  (when
determined)  are minimal concentrations  necessary  to block  propagation  in
motor nerve.
Chemical  pKa  pH  Arel  Cm(tot)t  CG(f.b.)§
10166  7.67  6.45  0.70  0.77  0.22
6603  9.80  6.45  0.70
QX-314  - 6.45  1.00
Xylocaine  7.85  6.45  0.70
Xylocaine  7.85  7.80  1.30  3.79  0.82
L-30  8.96  6.45  0.82  36.00  0.76
10666  8.21  6.45  1.06
QX-222  - 6.45  1.08
QX-222  - 7.80  1.08
14465  7.35  6.45  1.10
14465  7.35  7.80  2.30  11.1  5.14
10766  9.511  6.45  2.40  25.4  2.73
Procaine  8.92  7.45  0.46  14.4  0.26
Xylocholine  - 6.45  0.74
* A,e  , concentration necessary  to reduce  early amplitude of the end plate potential  to 5  mv di-
vided by the concentration  of QX-314 at pH 6.45 required for the same reduction. Typical abso-
lute concentration ofQX-134 = 0.3 m.
t  C,(tot), extrapolated  minimum  concentration  (m)  required  to  block conduction  in  nerve.
Data from Ehrenberg  (8).
§ C,(f.b.),  calculated  minimum concentration of free base.  Data from Ehrenberg  (8).  Measure-
ments carried out at pH 7.78 on sheathed  nerve.
jI  pK.  determined only as 9.0 to 9.5.
ular structure  is  similar to that of procaine,  but it has  a lower pK.  (7.85  as
opposed  to  8.92  [19]),  which  enables  one  to  determine,  by  changes  in  ex-
ternal pH, whether the charged  or uncharged  form of the molecule  is  active.
'Xylocaine  was  synthesized  by  N.  Lfgren  (19)  and  is  manufactured  by  Astra  Pharmaceutical
Products Inc., Worcester,  Mass.  I am indebted to this company for gifts of Xylocaine and derivatives.
Other  drugs were purchased commercially.
145THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  · VOLUME  52  I968
METHODS
Two muscle  preparations with attached  motor nerve  supply were  used in this study;
the  sartorius  (9)  and  the  extensor  digitorum  longus  IV (EDL  IV)  (16)  of the  frog
Rana pipiens.
An intracellular micropipette was used to record voltage  across the end plate mem-
brane  (9).  In  some  experiments,  an  extracellular  micropipette  was  used  to record
external  miniature  end plate  potentials  (e.m.e.p.p.'s)  which  provided  an  indication
of the end plate current through that spot  (2, 3,17,  18).  An indifferent  calomel/agar-
Ringer electrode  was used in the  bath.
E.p.p.'s were evoked  by stimulating the motor nerve.  Iontophoretic  pulses of ACh
lasting longer than  those released  by the nerve  terminal were  applied directly to the
end plate (4-6),  using a  micropipette  filled with 3  M  ACh connected  through  a large
resistance  to a  DC  source (for applying  a "braking"  current)  in parallel with a pulse
generator.  In a few  experiments  double or  triple  barreled  micropipettes  were  used,
one  of the  barrels  always  being  filled  with  ACh  or  carbachol  (for  techniques,  see
references  4-6).
The pH's of all solutions  were adjusted within the range  6 to 8 with 10 mM glycyl-
glycine-piperazine  buffer  (Documenta  Geigy  Scientific Tables,  1962,  page  314).  To
ascertain  that  this  buffer  did  not  produce  unwanted  side  effects,  all  results  were
checked with phosphate-buffered  solutions. The standard Ringer contained  111.3 mM
NaCl,  2.1  mM KC1,  and  1.8 m  CaC12. The drugs used other than carbachol,  ACh,
and d-TC are listed in Table I, and henceforth the term "drugs" used without quali-
fication will refer to those listed.  In most experiments,  these drugs were applied by re-
placing  the  bath  solution  with  the  drug  solution  in Ringer's.  Changes  of the  bath
solution  could be completed within 20 sec.
RESULTS
The Effects  of Xylocaine on  the End Plate Potential
Xylocaine  and its  derivatives  reduced  the  amplitude  and  modified the  time
course  of the  e.p.p.  (Figs.  1 and 2).  (All  e.p.p.'s  shown  are  reduced  in  am-
plitude  relative to the e.p.p.  in Ringer's which  has an amplitude  in excess  of
30  mv  [9,  26].)  The effects  of any  one drug  at a given  concentration  were
reproducible  and  could  be  reversed  in  less  than  3  min  by  washing  with
Ringer's.  In different  fibers  the  amplitude  of the  e.p.p.  during  treatment
with any  drug at  a  given  concentration  varied  over  a  fourfold  range.  This
variation  was  not  clearly  linked  to variations  in  resting  potential  or  in  the
passive  electrical  properties  of  the  muscle  fibers.  The  e.p.p.'s  illustrated  in
Figs.  1  and  2  were  obtained  from  a  single  muscle  fiber  by  intracellular
recording.  Each  record  is  a  photographic  superposition  of  three  successive
e.p.p.'s.  Between  tests  with  each  drug,  the  preparation  was  washed  with
Ringer's,  and then  treated with  a standard  concentration  of d-TC, allowing
the same equilibration  time in each case.  Only one of these control responses
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FIGURE  1.  Comparison  of the effects  of Xylocaine  derivatives  on the e.p.p.  in a single
EDL  IV  fiber,  resting  potential  -89  my.  Each  chemical  was  applied,  the  resulting
e.p.p.  was  recorded  for  several  successive  nerve  stimulations,  plus  a base  line  trace
without stimulation,  the  chemical  was  washed out with Ringer's,  and  the  response in
the presence  of d-TC was reexamined  before applying  the next  chemical.  A, 0.004 mM
d-TC.  B,  0.56 mM Xylocaine.  C,  0.39 mm L-30.  D, 0.34  mm 6603.  E,  1.02 mm  14465.
F, 1.6 mm QX-222 (note different voltage scale).  G, 0.96 mM  10666. H, 1.07 mrm  10766.
pH 6.8. Calibration pulses  at the  beginning of each  trace,  1 my,  1 msec.  The rapidly
rising phase of the e.p.p.  in (F) is not clearly resolved but could be seen at higher sweep
speed  (e.g.,  Fig.  4  C,  right).
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FzouRE 2.  Comparison of the effects of various Xylocaine  derivatives (same experiment
as that  in Fig.  1, but at 5 times  higher sweep  speed).  A, 0.005  nM  d-TC. B,  0.37 mrn
Xylocaine.  C, 0.40  mM L-30. D, 0.34 mM 6603. E, 0.32 mM QX-314.  The e.p.p.  shown
in E was very similar to those produced (in the same preparation)  during treatment with
0.4  mM FB-I, xylocholine,  or 0.7 mn  10166.  pH 6.8. Calibration  pulses on  each trace
1 mv,  1 msec.
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is  shown  in  each  figure  but  they  remained  identical  through  the  series  of
solution changes.
To facilitate  discussion  of  the  effects  of  the  drugs,  it  is  useful  to  specify
the  various  phases  of the  e.p.p.  in  greater  detail,  using  Fig.  1 A  and  B  as
paradigms.  The  early  brief component  of the  e.p.p.  refers  to  the  initial  rapid
rise  (depolarization)  and  early  fall;  this  component  is  curtailed  by  the
drugs. The  maximum  early amplitude is defined  as the maximum  amplitude  of
the e.p.p., or the amplitude at which the initial rapid rise changes abruptly to
a  slow  rise  (e.g.,  Fig.  4  C,  right).  The  term prolonged component  refers  to  a
prolongation  of depolarization  seen  during  treatment  with Xylocaine  and
some of its derivatives, but not during treatment with d-TC,  where the dura-
tion of the falling phase of the e.p.p. primarily reflects the passive impedance
of the muscle fiber membrane  (9,  26).
,  S
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FIGURE  3.  Tracings  of e.p.p.'s  (EDL IV)  showing effects  of increasing  concentrations
of d-TC (dashed  lines) and Xylocaine  (solid lines).  The upper curves were produced by
0.001  mM  d-TC  and 0.08  mM  Xylocaine,  respectively;  the  lower  ones  by  0.005  mM
d-TC  and 0.24 mM  Xylocaine.  The solution pH  was 6.8.
THE  EARLY  BRIEF  COMPONENT  All  the  drugs  reduce  the  early  ampli-
tude  of the  e.p.p.  in  proportion  to  their concentration,  with  slight  differ-
ences  in relative effectiveness  (Table  I, column  4).  They  have  qualitatively
similar effects on  the early time course of the e.p.p., and there  are  no obvious
differences that might be correlated with molecular structure. During treatment
with  the  drugs,  recorded  e.p.p.'s  typically  have  a  shorter  time  of initial
rise than during treatment  with d-TC  (average  52%  of the time  of rise  seen
in d-TC,  range 38 to 71%,  15 experiments tabulated).  d-TC reduces  the am-
plitude of the e.p.p. in proportion to the concentration  applied, but produces
little change  in time course  (Fig.  3). Thus the time to the peak is  not greatly
changed,  and the  absolute rate  of rise  of the e.p.p.  is reduced  in proportion
to the  concentration  of d-TC.  Xylocaine  and  its derivatives  also  reduce  the
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amplitude  of  the  e.p.p.,  but  reduce  only  slightly  the  absolute  rate  of rise
(Fig.  3),  and  thus  shorten  the  rise  time,  especially  relative  to  an  e.p.p.  of
equal amplitude during treatment  with d-TC.
In instances in which the e.p.p.  has no prolonged component,  for example,
in a  muscle  treated  with drug  10766  (Fig.  1 H),  the  early  rapid  fall  of the
e.p.p. is very fast.  In other cases (e.g.,  Fig.  1 E and F), the early fall is barely
noticeable or obscured altogether  by the prolonged component.
A
K1e-.je  -
pH  7.6  pH  6.5
FIGURE  4.  Effect  of change  in solution  pH  on the  action of Xylocaine  and  two of its
derivatives,  A, Xylocaine,  total concentration  at both values  of pH, 0.6 m.  B, QX-314,
total concentration 0.53 m.  C,  14465, total concentration  1.0 mM. The waveforms shown
in (A)  and  (B) were taken from a  single preparation of EDL IV: calibration  bars  I my
and  5  msec.  Those  in  (C)  were taken from  a different  preparation,  calibration  pulses
1 msec  and  1 mv.
THE  PROLONGED  COMPONENT  OF  THE END  PLATE  POTENTIAL  The relative
amplitude  of the prolonged  component  of the  e.p.p.  (Vp)  will  be defined  as
its maximum amplitude  divided by the  maximum early amplitude.  Its pres-
ence  and  amplitude  are  definitely  related  to  the molecular  structure  of the
drugs.  The value  of  Vp  produced  by a  given  drug at  a constant  concentra-
tion  varies  slightly  from  preparation  to  preparation.  However,  the  samples
shown  in  Figs.  1 and 2  are  typical and  the following  structure-activity  rela-
tions were  observed  in all preparations.  (a)  Vp  depends critically on  the sub-
stituents  on  the  terminal  nitrogen.  The  derivatives  with  three  ethyl  or  two
ethyl or two  propyl  (or butyl)  groups produced no  prolongation  (Fig.  2  E).
The  derivative  with  two  methyl  groups  and  its quaternary  analogue  (drug
,50
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QX-222)  produce  a  much larger  V,  than Xylocaine  itself  (Fig.  1 E and F).
(b)  There  appears  to  be  an  optimum  distance  of separation  between  the
carbonyl  group and terminal  nitrogen,  since  the derivative  with two carbon
atoms  (drug L-30)  produces  a larger  V, than  does Xylocaine  or drug  6603
(Fig.  1 B,  C,  and D). This  optimum  is  not  related  in  any obvious  way  to
differences  in  the  ionization  constant  (pK,)  of  the  three  drugs  (Table  I).
(c) The carbonyl group of Xylocaine is essential for production of a prolonged
component. Neither drug  10766  (Fig.  1 H)  nor xylocholine  (TM-10,  Smith
Kline  and  French  Laboratories,  (Philadelphia,  Pa.),  Fig.  2  E)  produces
prolonged  components  of  the  e.p.p.  (d)  The  substituents  and  electronic
TABLE  II
CHANGES  IN AMPLITUDE  OF THE  E.P.P.  DURING
TREATMENT WITH DRUGS PARTIALLY  CHARGED  AS A
RESULT  OF  A  CHANGE  IN  pH
The pK.'s of four drugs are listed; from these the increase in effective  concen-
tration of the charged  form of each drug was calculated from the Henderson-
Hasselbach equation for the pH change 7.8  to 6.5; Column C shows the ratio
of the concentrations  (in charged form)  at pH 6.5  to the concentrations  (in
charged form)  at  pH 7.8.  Changes  in the  early  amplitude  component  are
shown in column A  E.A.  and changes in the prolonged component are shown
in column A  V,  .The ranges shown are those obtained in three experiments.
The values  are  the ratio  of the amplitude  of the component  after  the pH
change  to  the amplitude  under control  conditions.  A dashed  line  indicates
that no change  in amplitude was observed.
Chemical  pK,  C  AE.A.  AVP
Xylocaine  7.85  1.8  1/1.4-1/2.1  1.6-2.5
14465  7.35  3.3  1/2.1-1/3.0  2.6-3.5
L-30  8.96  1.1  1/1.1  -
Procaine  8.92  1.06  -
structure  of the  xylyl ring are  significant  in determining  the  action of Xylo-
caine.  Drug  10666  (Fig.  1 G),  lacking  2-,  6-substituents,  produces  a larger
Vp than does Xylocaine,  while the derivative with propyl groups on the xylyl
ring  (drug FB-1,  Fig.  2  E)  and that with an  additional  methyl group in  the
4-position  (drug  LL-31,  Astra  (not  illustrated))  produce  no  prolonged
component.  (e) The amide linkage of Xylocaine apparently  confers no special
properties  on the  molecule,  since  procaine  (which has an ester linkage)  pro-
duces  a  Vp  equivalent  to  that  produced  by  Xylocaine  at pH  6.5  (see  next
section).
Effects of pH
Lowering  the pH  of the  bathing  solution  is  known  to  decrease  the perme-
ability of the muscle membrane to chloride ions  (14,  15),  and to decrease the
quantum  content of the  e.p.p.  ([7]  and  unpublished  personal  observations).
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FIcGRE  5.  Internally  (A,  B,  E, F)  and externally  (C,  G) recorded  m.e.p.p.'s  from  a
single preparation  of EDL IV, resting potential  about  -85 my. A,  B, C, during treat-
ment with 0.02  mM Xylocaine;  E, F, G, in Ringer's. pH 6.8. Sweep duration in A, C, E,
and G,  140 msec.  Sweep duration  in B and F, about 20 msec. The decrease in amplitude
produced  is  apparent  when  A  and  E  are  compared.  The  prolongation  produced  by
Xylocaine  is apparent when  C and G are compared.  The calibration bar in C indicates
I mv for  entire figure.
In  standard  Ringer's  solution  within  the pH  range  6  to 8,  these competing
direct  effects  of hydrogen  ions  balance  each  other,  and  the  action  of  qua-
ternary  derivatives  of Xylocaine  (and  that  of  d-TC)  was  not  affected  by
changes  in  solution pH (Table  I,  Fig. 4 B).
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The  actions  of Xylocaine  and  its  partially  charged  derivatives  were  de-
finitely influenced  by pH. Decreases in external pH decreased  the maximum
early amplitude  of the  e.p.p.  and  increased  V,  (Fig. 4).  Both changes simu-
lated  changes  produced  by  increasing  the  drug  concentration,  and  were
consistent  with  calculations  based  on  the  Henderson-Hasselbach  equation
if one postulates that only  the charged form of the drugs  is active (Table II).
The Effects  of Xylocaine on the Miniature End Plate Potentials
Xylocaine  and its  derivatives  decrease  the amplitude  of miniature end plate
potentials  (m.e.p.p.'s)  and produce  modifications of their time course  similar
to  those  observed  in  the e.p.p.,  in  agreement  with  results  reported  for  the
effect  of procaine  (20)  (Fig.  5).  A  drug concentration that reduced  the  am-
plitude  of m.e.p.p.'s  to  about half  (0.05-0.08  mM)  reduced  the  time  of rise
of the waveform  by about  30%  (seven  experiments),  though  there  was  no
FIGURE  6.  Tracings  of internally  and externally  recorded m.e.p.p.'s in EDL IV. Since
internal (top traces a and b) and external (bottom traces a' and b') records were made at
different times, a'  is not the current producing  a (a, a') in standard  Ringer's.  (b, b') in
Ringer's plus 0.05 mm Xylocaine,  pH 6.5.
indication  that  the  absolute  rate  of rise  was  increased.  The  time  course  of
e.m.e.p.p.'s was also altered  (Fig. 6), but never showed a minimum separating
the early  transient  component  from  the  prolonged  component,  even  during
treatment  with  drugs  that  produced  such  a  minimum  in  the  e.p.p.  (e.g.,
Fig.  1 E)  (see [25]).
Deciding Where Xylocaine Acts
The  known  events  governing  the  amplitude  and  time  course  of the  e.p.p.
may  be  separated  under  five  main  headings:  the  presynaptic  nerve  action
potential,  the  presynaptic  release  of ACh,  the  reaction  of ACh  with  post-
synaptic  receptors,  the  hydrolysis  of ACh  by acetylcholinesterase  (AChE),
and  the  charging  of the  membrane  capacitance  of the  muscle  by the  end
plate  current.  The  following  observations  concern  possible  effects  of  the
drugs  other  than those  on  the postsynaptic  receptors  and  indicate  that such
actions  probably  do not significantly  contribute  to the  effects  of Xylocaine
and its derivatives  at the neuromuscular junction.
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Table  I shows  that there is no correlation between  local anesthetic  activity
(columns  5  and  6)  and relative  neuromuscular  blocking  effectiveness  of the
drugs  (column  4).  Block  of the  action potential  in  the  nerve  terminal  pro-
duces  a  sudden  and  complete  loss  of the  e.p.p.,  but this  occurs  for  most of
these  drugs  only  at  concentrations  above  2  m.  Furthermore,  some  drugs
that  have  effects  on  the  e.p.p.  have  no  detectable  effects  on  electrical  ex-
citability.  At  10  m,  neither  QX-314  nor QX-222,  both quaternary  deriva-
tives  of Xylocaine,  has  any  effect  on  the  electrical  excitability  of muscle  or
on the  propagation  of  the  action  potential  in  the  desheathed  nerve  trunk.
At 4  mM  QX-314  has  no  effect  on  the  ionic  currents  in isolated  frog  nodes
I mv
0  2  4  6  8  10
Msec
FIGURE  7.  Comparison  of e.p.p. waveforms  (traced from photographic  records)  before
and after the addition of 0.1  mm neostigmine  to the solution bathing the EDL IV muscle.
With  both  d-TC  treatment  (dashed  lines) and  Xylocaine  treatment  (solid  lines)  the
larger  amplitude  waveforms  are  those  obtained  after  AChE  inhibition.  However,  the
basic effects  of Xylocaine  remain in evidence.
of Ranvier  (13),  whereas  0.1  mM  Xylocaine  reduces  the  amplitudes  of the
sodium  currents  to  about  one-half  in  such  preparations  (12).  The  relations
between  molecular  structure  and  the  value  of  V,  are  not  correlated  with
increasing  local  anesthetic  activity  (11,  23).  The  prolonged  component  is
not the  result of repetitive  activity in the nerve  terminal,  since this produces
repetitive  e.p.p.'s.  It  might  be  produced  by  prolonged  depolarization,  but
this would not account for prolongation  of the m.e.p.p.'s.
Xylocaine  and  its  derivatives  have  no  significant  effect  on the  quantum
content  of the  e.p.p.  (see  reference  22  for  discussion  of quantum  content).
Concentrations  of the drugs higher  than 0.05  mM reduce the m.e.p.p.  ampli-
tude below the base line noise and do not produce the "quantally"  fluctuating
responses  that occur during  treatment  with  drugs  which  have  a  strong  pre-
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synaptic depressant  action.  Slight presynaptic  effects masked by  strong post-
synaptic  actions would not have been detected in the present experiments.
It  is natural  to  suggest  that  the  prolongation  of the  e.p.p.  produced  by
Xylocaine  and  its  derivatives  might  be  the  result  of AChE  inhibition.  But
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FIGURE  8.  Tracings which illustrate the effects of Xylocaine derivatives on the response
of end plates  of single  sartorius fibers  to iontophoretic  application  of ACh. A,  pH 6.4;
(1),  response in Ringer's before adding chemical;  (2),  response  in Ringer's plus 0.05 mM
14465; (3),  response in Ringer's plus 0.05 mM QX-314. B, different preparation,  pH 6.5;
(1),  response  in Ringer's  before adding chemical.  (2),  response  in Ringer's  plus 3.3  mM
14465.  (3),  response  in Ringer's  plus  14465  after five  successive pulses  of ACh spaced 3
sec apart;  (4), response  in Ringer's after washing out the chemical.  C, different prepara-
tion, pH 6.4;  (1), response  in Ringer's.  (2), response  in Ringer's plus 4.0 mm  14465;  (3),
response  in Ringer's  plus 2.0 mM  14465;  (4),  response  in Ringer's plus  0.52  mM  14465.
The increase in response  (A,  trace 2)  was not always observed.
not  only  are  the  prolongations  produced  of longer  duration  than  the  pro-
longation  of the  entire  e.p.p.  produced  by  known  inhibitors  of AChE  in
normal Ringer's  (9,  26), but also the presence of either 0.1 mM neostigmine or
diisopropylflurophosphate  (DFP)  does  not  affect  the  change  in  waveform
produced by Xylocaine  (Fig.  7).
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FIGURE  9.  Effects  of  iontophoretic  application  of  QX-222  or  Xylocaine  on  ionto-
phoretically  evoked responses  to  ACh in sartorius  muscle.  In each record  (a) indicates
application  of ACh,  and  (d)  the application  of the  drug; the  current pulses  used  are
shown in the lower traces,  while the letters alongside voltage traces distinguish  between
responses.  A,  effect  of a pulse  of QX-222  applied  before  a  pulse  of ACh.  B,  effects  of
increasing  pulses  of QX-222  applied  at the  same time  as  a standard  pulse  of ACh.  C,
effects of a pulse of QX-222 applied  after a pulse  of ACh.  D, effects  of a pulse of Xylo-
caine applied  before a pulse of ACh.  E, effect of Xylocaine  applied at the same time as
ACh.  Note  that  traces  cross-over  in A,  B,  and  C.  Horizontal  bars  (on each record):
A, D  =  10 msec; B,  C,  E  =  20 msec.  Vertical bars: A,  B, C  =  1 mv, 4  X  10-s amp;
D,  E  =  0.5  mv,  2  X  10- 7 amp.  See  text  for discussion.  M.e.p.p.'s  happen  to  occur
during many traces.
At concentrations  up to 2  mM Xylocaine  and its derivatives have  no effect
on the passive  electrical properties of muscle fibers bathed in normal Ringer's.
At any concentrations  below  20 m,  none of the  chemicals  depolarizes  the
muscle when applied in the bathing solution.
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These  observations  suggest  that  the  modifications  of  the  time  course  of
the  e.p.p.  and  of the  m.e.p.p.  by Xylocaine  and  its  derivatives  do  not  de-
pend  on  changes  in  the  presynaptic  terminal,  in  the  activity  of AChE,  or
in  the impedance  of the  muscle  fiber.  Thus  the postsynaptic  receptors  seem
to be the sites at which  the drugs act.
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FIGURE  10.  Effects  of  iontophoretic  application
of  QX-222  on  evoked  responses  to  carbachol.
Identifying letters under lower current traces and
alongside  voltage  traces as  in  Fig.  9,  with  (c)  =
(carbachol) substituted for (a)  =  (ACh).  A,  pro-
longation  and  depression  produced  by a pulse  of
QX-222  applied  before  a  pulse  of  carbachol.  B
and C, effects of a pulse of QX-222  applied at two
times after a pulse of ACh. Note  that  even after 50
msec,  the drug can produce  a  slight  prolongation
of  response;  traces  cross-over  in  each  record.
Horizontal  bars:  A  =  10  msec,  B and  C  =  20
msec.  Vertical  bars: A  =  1 my,  10 - 7 amp; B and
C  =  1 my,  10-6 amp.  (B) and  (C)  were recorded
at the same end plate.
Effects  of Xylocaine and Derivatives on  the Response to Iontophoretically Applied
Acetylcholine
EFFECTS  OF  DRUGS  IN  THE  BATHING  SOLUTION  Xylocaine  itself  and
derivatives  that  produce  relatively  small  amplitudes  of  V,,  significantly
depress  the  response  to  iontophoretically  applied ACh  (Fig.  8).  Drugs such
as QX-222  and  14465  that produce  large values  of V,  (i.e.,  large prolonged
components  of the e.p.p.)  are much less effective  in depressing  the  response
to  ACh  (Fig.  8  A  and  C).  The  highest  concentrations  of such  drugs  used
(>6  mM)  failed  to  eliminate  iontophoretically  evoked  responses  to  ACh.
However,  these  drugs  did  depress  the  early  rising  phase  and  enhance  the
late  falling  phase,  causing  a general  lengthening  of  the  response  (Fig.  8  B
I-
C
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and  C).  At  very  low  concentrations  drugs  QX-222  and  14465  sometimes
increased  slightly  and  transiently  the  amplitude  of iontophoretically  evoked
responses to ACh.
EFFECTS  OF  BRIEF  PULSES  OF  DRUGS  Using  multiple  barrelled  pipettes,
the effects of pulses of Xylocaine and QX-222 on the response  to a test pulse
of ACh  or carbachol  were  examined  in  five  preparations  (Figs.  9  and  10).
A pulse  of QX-222  delivered  before a pulse of ACh reduced  the rate of rise
and  prolonged  the  time  course  of the  test  response,  producing  only  slight
depression in peak amplitude  (Fig.  9 A). A pulse of Xylocaine delivered  with
similar timing produced depression with slight prolongation  (Fig.  9 D).
The effects  of increasing  pulses of drug QX-222  applied at  the same time
as a  standard pulse  of ACh are  shown  in Fig.  9  B. The degree  of prolonga-
tion, relative to depression of peak  amplitudes,  varied  at different  end plates
in  the  same preparation,  but  was always  much greater  than in  the  case  of
Xylocaine  (Fig.  9 D  and E).
If  a pulse  of QX-222  was  applied after  a pulse  of ACh or carbachol,  the
drug  produced  a  characteristic  effect  as  long  as  the  response  to  ACh  was
visible. This consisted of an early phase of depression,  and  a later  prolonga-
tion  (Figs.  9  C  and  10  B and  C).  Xylocaine  produced  the  depression,  but
only slight prolongation  (not shown).
The effect  of a drug  pulse appeared  to  last only  slightly  longer than  the
depolarization  produced  by a  brief pulse  of ACh,  and  it  was  considerably
briefer  than the  depression  following  a pulse  of d-TC.  The drugs  produced
no  depolarization  when  applied  alone.  All  these  effects  were  observed  in
preparations  treated  with  0.1  mM  neostigmine,  and  similar  effects  were
observed  when  carbachol  was  substituted  for ACh  (Fig.  10).  Even with the
briefest responses observed  (rise time  5-8 msec)  there was  no sign that either
Xylocaine  or  QX-222  produced  an  early  brief  component  similar  to  that
seen in the e.p.p.  This was due to the relatively  slow time course  of applica-
tion  of ACh,  compared  with  that  released  from the  nerve  terminal;  e.p.p.'s
with  two  maxima  occur  both  because  of  the  time-variant  effects  of Xylo-
caine,  and  because  of  the  impedance  properties  of  the  muscle  membrane
(24, 25).
DISCUSSION
The  action of  Xylocaine  at  the  neuromuscular junction  seems  unrelated  to
its  action  as  a  local  anesthetic.  Quaternary  drugs  that  affect  the  neuro-
muscular junction  are inactive  as local  anesthetics,  and considering all deriv-
atives  tested,  there  is  no  correlation  between  local  anesthetic  activity  and
changes  in  amplitude  or  time  course  of  the  e.p.p.  Although  some  drugs
block  presynaptic  electrical  activity  at  concentrations  above  2.0  mM,  the
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full  range  of effects  noted  (on e.p.p.'s,  m.e.p.p.'s,  and  responses  evoked  by
iontophoretically applied ACh)  is unlikely to  be  the  result  of a  presynaptic
effect.
Although  local  anesthetics  may  inhibit  AChE  activity,  and  can  modify
the  passive  impedance  of cell  membranes,  the  experimental  evidence  pre-
sented  suggests  that  neither  of  these  possible  actions  is  significant  when
considering  the  effects  of the  drugs  at  the  neuromuscular  junction.  Taken
alone, the range of effects of the drugs indicates an action on the postsynaptic
receptors  for ACh;  the supplementary  evidence  suggests that this is the only
significant locus of action.
The molecular  properties  of Xylocaine  and  its  derivatives  that appear  to
be  important  in  causing  a  prolongation  of  the  e.p.p.  are:  (a)  a  charged
terminal  nitrogen,  preferably  a methonium  moiety;  (b)  a  carbonyl  group;
(c)  a  distance  of  about  6  A  separating  terminal  nitrogen  and  carbonyl;
and  (d)  a terminal ring of certain optimal  properties.  With  the exception  of
(d)  these  properties  are  identical  with  the  molecular  properties  of  ACh
known  to be important  in the activation  of receptors  (1)  and different  from
the properties  of good  local  anesthetics  (11,  23).  Since  sites  of action  other
than  the  postsynaptic  receptors  are  not  likely,  the  Xylocaine  derivatives
must  be capable  of blocking  ACh  receptors.  Thus,  although  the  two  main
effects  of the drugs-a prolonged  activation  of end plate current,  and a  de-
pression of receptor  response  causing the decrease in early peak amplitude-
are  very  different,  the  available  evidence  suggests  that  they  involve  the
binding of the drugs to the same,  or very similar receptors.  Furthermore,  the
two  effects  on  the  e.p.p.  produced  by  the  drugs  cannot  be  separated  by
changes in concentration  or  in pH; a  decrease  in the amplitude  of the early
component  is  always  accompanied  by an  increase  in  Vp,  and vice  versa.  If
two  separate  sites  of action  were  involved,  one  would  expect  that  such  a
separation could be obtained.
In experiments  in which the e.p.p. was recorded,  Xylocaine and its deriva-
tives  were  tested  at  a constant bath concentration.  Yet  within  the  temporal
sequence  of the  e.p.p.  the  drugs  produce  both depression  and  prolongation,
suggesting  that  their  action  is  dependent  on  the  time  course  of  receptor
activation  by ACh in a way that the action of d-TC is not. Such  dependence
could  mean  that  the  effects  of  the  drugs  on  the  iontophoretically  evoked
response  might  be  qualitatively  different  from  their  effects  on  the  e.p.p.
To  account  for  the  effects  of Xylocaine  and  its  derivatives  on  the  e.p.p.,
one  must postulate that  the depressant  action  producing  the  curtailment  of
the early brief component  is supplemented  within  1 to  2  msec  by an action
that  enhances  the  late falling  phase.  Because  of the  relatively  slow buildup
of ACh  near  the  receptors  during  iontophoretic  application,  it  is  not  sur-
prising that the  only  observed  effect  of the  drugs  on  the  early waveform  of
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iontophoretic  responses  is  depression;  the  brief transient  in  the  case  of the
e.p.p.  could  be  explained  if Xylocaine,  although  present  in  constant  con-
centration,  does  not  become  effective  until receptors  have been activated by
ACh.  This suggestion  fits  well  with  the  observation  that none  of the  drugs
produces  a  significant  depression  of  the  initial  rate  of  rise  of the  e.p.p.  It
also would explain  why both the drugs  tested produce an early depression  of
the  response  to iontophoretically  applied ACh  when  applied  in pulses  after
the pulse  of ACh  (Figs.  9  and  10).
Drugs  that  produce  a  large  prolonged  component  of the  e.p.p.  (large
V,)  also  prolong  the  response  to  iontophoretically  applied  ACh  after  de-
pressing  the early rate of rise  of the  response.  Although  the rate  of buildup
of ACh  is  slow during  iontophoretic  application,  the  total  amount  of ACh
should  become  large within  5  to  10 msec,  and any  enhancing  effect  of the
drugs  should then  become evident.  According  to  the hypothesis  discussed  in
detail in the following paper  (25),  the action of Xylocaine and its derivatives
that produces  the  curtailment  of  the  early  transient  of  the  e.p.p.,  and  the
early depression  of the  iontophoretically  evoked  response  to ACh,  also  leads
to the  production of some  stable  activated  receptors.  More of these  are pro-
duced by QX-222,  and thus  this drug  produces a relatively  large prolonged
component  of  the  e.p.p.,  and  a  great  prolongation  of the  response  to  ion-
tophoretically  applied  ACh,  while  Xylocaine  itself  produces  a  lesser  pro-
longed  component  (smaller  V)  and  little  prolongation  of  the  iontopho-
retically evoked response.  The two effects of any one  drug  can  take  place  at
any  time  after  ACh  has  begun  to  activate  receptors,  and  this  leads  to  the
effects  of QX-222  when  a pulse  of the  drug  is  applied  after  a pulse  of ACh
(Fig.  10).
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